# NLK

## Overview
Nemo-like kinase (NLK) is a gene that encodes a serine/threonine protein kinase, which plays a pivotal role in various cellular signaling pathways. The NLK protein is involved in the regulation of key processes such as inflammation, cell growth, and apoptosis, primarily through its interactions with other proteins and its ability to phosphorylate specific transcription factors. As a kinase, NLK is integral to the modulation of pathways like Wnt/β-catenin and NF-κB, where it acts as a negative regulator, thereby maintaining cellular homeostasis and preventing aberrant signaling. The gene's expression and the protein's activity are crucial in both normal physiological functions and pathological conditions, including cancer and neurodegenerative diseases. NLK's ability to influence diverse cellular processes underscores its potential as a therapeutic target in various disease contexts (Ishitani2013Nemolike; Chan2024Functional; Ishitani1999The).

## Structure
The human NLK (nemo-like kinase) gene encodes a protein with a kinase domain composed of 289 amino acids, extending from the 3' portion of exon 1 to the 5' portion of exon 9 (Harada2002Genomic). This domain shows a high degree of similarity to the kinase domains of ERK5 (MAPK7) and cyclin-dependent kinases (CDKs), indicating a conserved structure among these kinases (Harada2002Genomic). NLK is a serine/threonine protein kinase, and its activation involves autophosphorylation at Thr-286, a critical post-translational modification essential for its kinase activity (Ishitani2013Nemolike; Ishitani2011Homodimerization).

NLK forms homodimers, which are crucial for its activation and nuclear localization. This dimerization is dependent on the C-terminal Cys-425 residue, and mutations at this site can disrupt oligomerization and function (Ishitani2011Homodimerization). The kinase and C-terminal domains are required for oligomerization, suggesting a specific quaternary structure necessary for its biological activity (Ishitani2011Homodimerization). NLK's structure allows it to interact with various signaling pathways, including Wnt/β-catenin, where it phosphorylates transcription factors like LEF1, affecting their activity and stability (Ishitani2013Nemolike).

## Function
Nemo-like kinase (NLK) is a serine/threonine kinase that plays a crucial role in various signaling pathways in healthy human cells. It is involved in the negative regulation of inflammatory signaling pathways, such as the TAK1-IKK-NFKB pathway, by phosphorylating adaptor proteins TAB2 and TAB3. This phosphorylation inhibits their polyubiquitin binding, leading to the inactivation of TAK1 and suppression of NFKB activation, thereby reducing the expression of inflammatory factors (Chan2024Functional). NLK also regulates AP-1 activity by phosphorylating c-jun, impacting gene expression related to inflammation and cell growth (Chan2024Functional).

In the context of DNA damage, NLK stabilizes the tumor suppressor protein p53 by inhibiting its interaction with MDM2, preventing p53 ubiquitination and degradation. This stabilization enhances p53's DNA-binding ability and activity, promoting the expression of target genes involved in cell cycle regulation (Zhang2014Nemolike). NLK also acts as a negative regulator of the Wnt/β-catenin signaling pathway by phosphorylating TCF/LEF transcription factors, inhibiting their DNA-binding activity and transcriptional activation (Ishitani2013Nemolike; Ishitani1999The). These regulatory roles of NLK are essential for maintaining cellular homeostasis and preventing aberrant signaling that could lead to diseases.

## Clinical Significance
Nemo-like kinase (NLK) plays a significant role in various diseases due to its involvement in multiple signaling pathways. In cancer, NLK can act as either a tumor suppressor or an oncogene, depending on the tumor type. For instance, in colorectal cancer, NLK inhibits cell growth and promotes apoptosis, while in breast cancer, its nuclear localization is mediated by interaction with heat shock protein 27 (HSP27) (Daams2020NemoLike).

NLK is also implicated in neurodegenerative diseases, particularly those involving TDP-43 proteinopathies such as amyotrophic lateral sclerosis (ALS). Reduction of NLK enhances lysosome biogenesis, improving the clearance of aggregated TDP-43 proteins, which are associated with these disorders. This suggests that targeting NLK could be a therapeutic strategy for managing diseases characterized by protein aggregation (Tejwani2023Reduction; Tejwani2020Reduction).

In spinal and bulbar muscular atrophy (SBMA), NLK modulates androgen receptor activity, influencing disease pathology. Reduced NLK expression has been shown to alleviate SBMA symptoms in mouse models, suggesting its potential as a therapeutic target (Todd2015Nemolike). These findings highlight the clinical significance of NLK in disease development and progression.

## Interactions
Nemo-like kinase (NLK) is involved in various protein interactions that influence its regulatory functions. NLK interacts with the protein 14-3-3ζ, which is crucial for restoring E-cadherin expression in lung cancer cells. This interaction is significant because NLK disrupts the dimerization of 14-3-3ζ, which is necessary for its stability and function, thereby inhibiting cell migration and promoting E-cadherin expression (Chen2020NLK).

NLK also interacts with the mitochondrial antiviral signaling protein (MAVS), where it phosphorylates MAVS, leading to its degradation. This interaction is essential for regulating the antiviral innate immune response by negatively affecting type I interferon signaling (Li2019Phosphorylation).

In the context of NF-κB signaling, NLK negatively regulates this pathway by disrupting the interaction between TAK1 and IKKβ, thereby inhibiting the nuclear translocation of p65 and affecting the degradation of IκBα (Li2014Nemolike).

NLK also interacts with the Notch1 intracellular domain (Notch1ICD), phosphorylating it to suppress Notch signaling by interfering with the formation of the Notch active transcriptional complex (Ishitani2010Nemolike). These interactions highlight NLK's role in various signaling pathways and its impact on cellular processes.


## References


[1. (Chen2020NLK) Jie Chen, Qingfeng Lin, Tingting Ni, Jiyi Zhao, Feng Lin, Xiangdong Lu, Ye Lv, Shujuan Ren, Zhili Liu, Ting Zhang, Shuyan He, Dong Shen, and Weidong Mao. Nlk interacts with 14‑3‑3ζ to restore the expression of e‑cadherin. Oncology Reports, March 2020. URL: http://dx.doi.org/10.3892/or.2020.7557, doi:10.3892/or.2020.7557. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/or.2020.7557)

[2. (Tejwani2023Reduction) Leon Tejwani, Youngseob Jung, Hiroshi Kokubu, Sowmithra Sowmithra, Luhan Ni, Changwoo Lee, Benjamin Sanders, Paul J. Lee, Yangfei Xiang, Kimberly Luttik, Armand Soriano, Jennifer Yoon, Junhyun Park, Hannah H. Ro, Hyoungseok Ju, Clara Liao, Sofia Massaro Tieze, Frank Rigo, Paymaan Jafar-Nejad, and Janghoo Lim. Reduction of nemo-like kinase increases lysosome biogenesis and ameliorates tdp-43–related neurodegeneration. Journal of Clinical Investigation, August 2023. URL: http://dx.doi.org/10.1172/jci138207, doi:10.1172/jci138207. This article has 2 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1172/jci138207)

[3. (Ishitani1999The) Tohru Ishitani, Jun Ninomiya-Tsuji, Shin-ichi Nagai, Michiru Nishita, Marc Meneghini, Nick Barker, Marian Waterman, Bruce Bowerman, Hans Clevers, Hiroshi Shibuya, and Kunihiro Matsumoto. The tak1–nlk–mapk-related pathway antagonizes signalling between β-catenin and transcription factor tcf. Nature, 399(6738):798–802, June 1999. URL: http://dx.doi.org/10.1038/21674, doi:10.1038/21674. This article has 505 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/21674)

[4. (Ishitani2010Nemolike) Tohru Ishitani, Tomoko Hirao, Maho Suzuki, Miho Isoda, Shizuka Ishitani, Kenichi Harigaya, Motoo Kitagawa, Kunihiro Matsumoto, and Motoyuki Itoh. Nemo-like kinase suppresses notch signalling by interfering with formation of the notch active transcriptional complex. Nature Cell Biology, 12(3):278–285, January 2010. URL: http://dx.doi.org/10.1038/ncb2028, doi:10.1038/ncb2028. This article has 104 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/ncb2028)

[5. (Daams2020NemoLike) Renée Daams and Ramin Massoumi. Nemo-like kinase in development and diseases: insights from mouse studies. International Journal of Molecular Sciences, 21(23):9203, December 2020. URL: http://dx.doi.org/10.3390/ijms21239203, doi:10.3390/ijms21239203. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms21239203)

[6. (Harada2002Genomic) Haruhito Harada, Shoko Yoshida, Yukiko Nobe, Yoichi Ezura, Tomoko Atake, Tomoko Koguchi, and Mitsuru Emi. Genomic structure of the human nlk (nemo-like kinase) gene and analysis of its promoter region. Gene, 285(1–2):175–182, February 2002. URL: http://dx.doi.org/10.1016/s0378-1119(02)00412-2, doi:10.1016/s0378-1119(02)00412-2. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/s0378-1119(02)00412-2)

[7. (Zhang2014Nemolike) H-H Zhang, S-Z Li, Z-Y Zhang, X-M Hu, P-N Hou, L Gao, R-L Du, and X-D Zhang. Nemo-like kinase is critical for p53 stabilization and function in response to dna damage. Cell Death &amp; Differentiation, 21(10):1656–1663, June 2014. URL: http://dx.doi.org/10.1038/cdd.2014.78, doi:10.1038/cdd.2014.78. This article has 34 citations.](https://doi.org/10.1038/cdd.2014.78)

8. (Chan2024Functional) Functional characterization of protein kinase NLK (nemo-like kinase). This article has 0 citations.

[9. (Li2014Nemolike) Shang-Ze Li, Hui-Hui Zhang, Jun-Bo Liang, Yang Song, Bing-Xue Jin, Na-Na Xing, Guo-Chang Fan, Run-Lei Du, and Xiao-Dong Zhang. Nemo-like kinase (nlk) negatively regulates nf-kappa b activity through disrupting the interaction of tak1 with ikkβ. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1843(7):1365–1372, July 2014. URL: http://dx.doi.org/10.1016/j.bbamcr.2014.03.028, doi:10.1016/j.bbamcr.2014.03.028. This article has 27 citations.](https://doi.org/10.1016/j.bbamcr.2014.03.028)

[10. (Ishitani2011Homodimerization) Shizuka Ishitani, Kenji Inaba, Kunihiro Matsumoto, and Tohru Ishitani. Homodimerization of nemo-like kinase is essential for activation and nuclear localization. Molecular Biology of the Cell, 22(2):266–277, January 2011. URL: http://dx.doi.org/10.1091/mbc.e10-07-0605, doi:10.1091/mbc.e10-07-0605. This article has 28 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1091/mbc.e10-07-0605)

[11. (Li2019Phosphorylation) Shang-Ze Li, Qi-Peng Shu, Yang Song, Hui-Hui Zhang, Yi Liu, Bing-Xue Jin, Tian-Zi Liuyu, Chao Li, Xi-Chen Huang, Run-Lei Du, Wei Song, Bo Zhong, and Xiao-Dong Zhang. Phosphorylation of mavs/visa by nemo-like kinase (nlk) for degradation regulates the antiviral innate immune response. Nature Communications, July 2019. URL: http://dx.doi.org/10.1038/s41467-019-11258-x, doi:10.1038/s41467-019-11258-x. This article has 39 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-019-11258-x)

[12. (Ishitani2013Nemolike) Tohru Ishitani and Shizuka Ishitani. Nemo-like kinase, a multifaceted cell signaling regulator. Cellular Signalling, 25(1):190–197, January 2013. URL: http://dx.doi.org/10.1016/j.cellsig.2012.09.017, doi:10.1016/j.cellsig.2012.09.017. This article has 56 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.cellsig.2012.09.017)

[13. (Todd2015Nemolike) Tiffany W Todd, Hiroshi Kokubu, Helen C Miranda, Constanza J Cortes, Albert R La Spada, and Janghoo Lim. Nemo-like kinase is a novel regulator of spinal and bulbar muscular atrophy. eLife, August 2015. URL: http://dx.doi.org/10.7554/elife.08493, doi:10.7554/elife.08493. This article has 18 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.7554/elife.08493)

14. (Tejwani2020Reduction) Reduction of Nemo-like kinase increases lysosome biogenesis and ameliorates TDP-43-related neurodegeneration. This article has 1 citations.